BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20036221)

  • 21. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
    Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
    Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
    Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
    Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats.
    Yuan CS; Attele AS; Dey L; Xie JT
    J Pharmacol Exp Ther; 2000 Oct; 295(1):177-82. PubMed ID: 10991976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR; Savastano DM; Covasa M
    Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors.
    Gulley S; Sharma SK; Moran TH; Sayegh AI
    Peptides; 2005 Sep; 26(9):1617-22. PubMed ID: 16112401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin (CCK) receptor and CCK gene expression in human pituitary adenomas and in vitro effects of CCK peptides on GH and gonadotrophin secretion.
    Oikonomou E; Charlton A; Buchfelder M; Adams EF
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):683-9. PubMed ID: 18058604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop.
    Oikonomou E; Buchfelder M; Adams EF
    Neuropeptides; 2008 Jun; 42(3):255-65. PubMed ID: 18423848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands.
    Crespi F; Corsi M; Reggiani A; Ratti E; Gaviraghi G
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2249-58. PubMed ID: 11060804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enterostatin (APGPR) suppresses the analgesic activity of morphine by a CCK-dependent mechanism.
    Takenaka Y; Shimano T; Yamada Y; Yoshida M; Ohinata K; Yoshikawa M
    Peptides; 2008 Apr; 29(4):559-63. PubMed ID: 18304696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution and functional characterization of lined seahorse (Hippocampus erectus) CCKs involved in fasting and thermal stress response.
    Zhang H; Qin G; Sun J; Zhang B; Lin Q
    Gen Comp Endocrinol; 2018 Jan; 255():56-63. PubMed ID: 29051075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orexigenic vs. anorexigenic peptides and feeding status in the modulation of fever and hypothermia.
    Szekely M; Petervari E; Szelenyi Z
    Front Biosci; 2004 Sep; 9():2746-63. PubMed ID: 15353311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid receptors and cholecystokinin in feeding inhibition.
    Alén F; Ramírez-López MT; Gómez de Heras R; Rodríguez de Fonseca F; Orio L
    Vitam Horm; 2013; 92():165-96. PubMed ID: 23601425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal CCK and thermoregulation: two receptors with different functions.
    Szelényi Z
    Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R109-11. PubMed ID: 16959866
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of a cholecystokinin/sulfakinin signalling system in Lophotrochozoa.
    Schwartz J; Dubos MP; Pasquier J; Zatylny-Gaudin C; Favrel P
    Sci Rep; 2018 Nov; 8(1):16424. PubMed ID: 30401878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to neuronal cholecystokinin.
    Beinfeld MC
    Peptides; 2001 Aug; 22(8):1197-200. PubMed ID: 11457511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ancient role of sulfakinin/cholecystokinin-type signalling in inhibitory regulation of feeding processes revealed in an echinoderm.
    Tinoco AB; Barreiro-Iglesias A; Yañez Guerra LA; Delroisse J; Zhang Y; Gunner EF; Zampronio CG; Jones AM; Egertová M; Elphick MR
    Elife; 2021 Sep; 10():. PubMed ID: 34488941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.